Literature DB >> 33673829

Plasma interleukin-21 levels and genetic variants are associated with susceptibility to rheumatoid arthritis.

Youguo Hao1, Lijun Xie2, Jing Xia1, Zhen Liu3,4, Baoxiu Yang5, Minqin Zhang6.   

Abstract

BACKGROUND: Rheumatoid Arthritis (RA) is a chronic inflammatory condition characterized by autoantibodies development and an elevated spectrum of pro-inflammatory cytokines. Previous reports highlighted a relationship between IL-21and the pathogenesis of RA. Although elevated IL-21 levels have been reported in RA patients, the association of common IL-21 genetic variants with a predisposition to RA development in the Chinese population lacks.
MATERIALS AND METHODS: Five hundred and fourteen Chinese subjects (healthy controls: 303 and rheumatoid arthritis patients: 211) were enrolled in the study. Clinical data of patients were collected from medical records, and patients were treated as per the guidelines. Common single nucleotide polymorphisms in the IL-21 gene (rs907715, rs2221903, rs2055979 and rs6822844) were genotyped by TaqMan SNPs genotyping method. IL-21 level in plasma of RA patients and healthy subjects was measured by ELISA.
RESULTS: The plasma level of IL-21 was significantly higher in subjects with rheumatoid arthritis relative to healthy controls (p < 0.0001). A positive correlation was observed between IL-21 level and DAS28 score, indicating the association of the cytokine with the worsening of the disease (Spearman r = 0.61, p < 0.0001). The prevalence of AA genotype (rs2055979) was significantly higher in RA subjects than in the controls (p < 0.0001, χ2 = 34.73, OR = 4.34, 95% CI = 2.623 to 7.219). Furthermore, elevated plasma IL-21 was observed in the rs2055979-AA genotype compared to CC type (p < 0.0001).
CONCLUSION: IL-21 plays a crucial function in rheumatoid arthritis pathogenesis. IL-21 rs2055979 polymorphism is associated with IL-21 plasma levels and is predisposed to RA development in the Chinese population.

Entities:  

Keywords:  Chinese; Interleukin-21; Polymorphism; Rheumatoid arthritis

Mesh:

Substances:

Year:  2021        PMID: 33673829      PMCID: PMC7936495          DOI: 10.1186/s12891-021-04111-0

Source DB:  PubMed          Journal:  BMC Musculoskelet Disord        ISSN: 1471-2474            Impact factor:   2.362


  37 in total

1.  2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

Authors:  Daniel Aletaha; Tuhina Neogi; Alan J Silman; Julia Funovits; David T Felson; Clifton O Bingham; Neal S Birnbaum; Gerd R Burmester; Vivian P Bykerk; Marc D Cohen; Bernard Combe; Karen H Costenbader; Maxime Dougados; Paul Emery; Gianfranco Ferraccioli; Johanna M W Hazes; Kathryn Hobbs; Tom W J Huizinga; Arthur Kavanaugh; Jonathan Kay; Tore K Kvien; Timothy Laing; Philip Mease; Henri A Ménard; Larry W Moreland; Raymond L Naden; Theodore Pincus; Josef S Smolen; Ewa Stanislawska-Biernat; Deborah Symmons; Paul P Tak; Katherine S Upchurch; Jirí Vencovsky; Frederick Wolfe; Gillian Hawker
Journal:  Ann Rheum Dis       Date:  2010-09       Impact factor: 19.103

Review 2.  Novel treatment strategies in rheumatoid arthritis.

Authors:  Gerd R Burmester; Janet E Pope
Journal:  Lancet       Date:  2017-06-10       Impact factor: 79.321

3.  Association of rs6822844 within the KIAA1109/TENR/IL2/IL21 locus with rheumatoid arthritis in the Algerian population.

Authors:  S Louahchi; I Allam; N Raaf; L Berkani; A Boucharef; A Abdessemed; N Khaldoun; N Bahaz; A Ladjouze-Rezig; A Nebbab; M Ghaffor; R Djidjik
Journal:  HLA       Date:  2016-02-24       Impact factor: 4.513

Review 4.  Interleukin-21: a multifunctional regulator of immunity to infections.

Authors:  John S Yi; Maureen A Cox; Allan J Zajac
Journal:  Microbes Infect       Date:  2010-09-09       Impact factor: 2.700

5.  Correlation of a multi-cytokine panel with clinical disease activity in patients with rheumatoid arthritis.

Authors:  Nataliya Milman; Jacob Karsh; Ronald A Booth
Journal:  Clin Biochem       Date:  2010-07-23       Impact factor: 3.281

6.  The association of interleukin-21 polymorphisms with interleukin-21 serum levels and risk of systemic lupus erythematosus.

Authors:  Yan Lan; Bin Luo; Jun-Li Wang; Yuan-Wen Jiang; Ye-Sheng Wei
Journal:  Gene       Date:  2014-01-13       Impact factor: 3.688

Review 7.  IL-21: a novel IL-2-family lymphokine that modulates B, T, and natural killer cell responses.

Authors:  Tania Habib; Andrew Nelson; Kenneth Kaushansky
Journal:  J Allergy Clin Immunol       Date:  2003-12       Impact factor: 10.793

Review 8.  Interleukin-21 in T cell-mediated diseases.

Authors:  Giovanni Monteleone; Massimiliano Sarra; Francesco Pallone
Journal:  Discov Med       Date:  2009-10       Impact factor: 2.970

9.  Neutralizing IL-21 and IL-15 inhibits pro-inflammatory cytokine production in rheumatoid arthritis.

Authors:  A K Andersson; M Feldmann; F M Brennan
Journal:  Scand J Immunol       Date:  2008-05-09       Impact factor: 3.487

Review 10.  Splicing mutations in human genetic disorders: examples, detection, and confirmation.

Authors:  Abramowicz Anna; Gos Monika
Journal:  J Appl Genet       Date:  2018-04-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.